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Summary Kytococcus schroeteri is a newly describedmicrococcal species and, to date, has been
associated mostly with endocarditis. Six infections attributable to this opportunistic pathogen
have been described since 2002, when the first case was identified. We describe here the first
pediatric case of a K. schroeteri ventriculoperitoneal shunt infection. The child was successfully
treated with a combination of rifampin and vancomycin and shunt replacement. Initially identified
as a Micrococcus spp. by both automated identification and conventional biochemical testing,
sequencing of the 16S ribosomal RNA gene enabled accurate identification of the organism.
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A 13-month-old male was referred to our institution to
undergo cardiac surgery. The baby was born at term in
Algeria, where a cyanotic cardiopathy was diagnosed. As
the boy grew older, an accelerated rate of growth of the
head was noticed and hydrocephalus was diagnosed. A ven-
triculoperitoneal shunt (VPS) was implanted in Algeria when
he was eight months old. During the postoperative course and
before admission to our hospital, the child had several
episodes of fever of unknown origin treated by either oral
amoxicillin or josamycin. By the time he was six months old,Published by Elsevier Ltd. All rights reserved.
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admission to our hospital in October 2005, he presented with
severemalnutrition (bodymass index of 12.8 kg/m2 [5 SD]),
relative macrocephaly (head circumference at 25th centile),
severe hypotonia and a mild respiratory distress syndrome.
He had been receiving josamycin for the past week for acute
otitis media. The antibiotic was stopped and, the day after,
the child was febrile (maximum temperature of 39.3 8C).
After three days of fever, a blood cell count revealed a white
blood cell (WBC) count of 31 500/mm3, with 36% polyneu-
trophils and 56% lymphocytes, and a C-reactive protein of
0.7 mg/dl. Acute otitis media was diagnosed and confirmed
by the otorhinolaryngologist. The child presented no clinical
signs of meningitis or intracranial hypertension. The VPS
valve was tapped as part of the initial assessment and
because of the history of recurrent fever for the past six
months. Cerebrospinal fluid (CSF) cytology and chemical
examination showed 81 WBC/mm3 (27 polyneutrophils, 59
lymphocytes, 11 monocytes), 809 red blood cells/mm3,
0.76 g/l of proteins, 24.7 mg/dl of lactic acid and 50 mg/
dl of glucose. A broad-spectrum empirical antibiotic therapy
was started for VPS infection: meropenem (100 mg/kg/day),
vancomycin (30 mg/kg/day) and rifampicin (20 mg/kg/day).
Direct Gram-stain examination of the CSF showed Gram-
positive cocci. The abdominal CT scan was normal and mer-
openem was stopped, as Gram-negative infection was ruled
out. After 24 hours, cultures of the CSF in Columbia agar
plates with 5% sheep blood incubated at 37 8C yielded an
abundant culture of yellow colonies of variable size sugges-
tive of Micrococcus spp. The L-alanine aminopeptidase test
was negative, confirming a Gram-positive microorganism. On
the GP card, the Vitek-2 automated identification system
(bioMe´rieux, Marcy l’Etoile, France) could not discriminate
between the three following bacteria Dermacoccus sp. versus
Kytococcus sedentarius versus Granulicatella sp. Additional
phenotypic tests were performed: the arginine dihydrolase
activity was positive, the catalase test was positive and
oxidase was negative. The isolate was susceptible to baci-
tracine (diameter >30 mm) (Rosco Neo-Sensitabs, Taastrup,
Denmark). Sensitivity testing was performed by E-tests on MH
plates (AB Biodisk, Solna, Sweden) incubated for 24 hours at
37 8C. The isolate was shown to be highly resistant to oxa-
cillin, penicillin (minimum inhibitory concentration [MIC]
>32 mg/ml), cephalosporins (MIC ceftriaxone >256 mg/ml)
and macrolides (MIC erythromycin = 12 mg/ml), and suscep-
tible to ampicillin (MIC = 4 mg/ml), gentamicin (MIC =
0.5 mg/ml), ciprofloxacine (MIC = 0.75 mg/ml), vancomycin
(MIC = 1 mg/ml), teicoplanin (MIC = 0.38 mg/ml) and mero-
penem (MIC = 0.38 mg/ml). As the identification was not
straightforward and the antibiotic susceptibility profile
was discordant with Micrococcus spp. identification, the
strain was investigated for complementary identification.
Determination of the 16S ribosomal RNA (rRNA) gene
sequence was performed as previously described1, revealing
a 99.9% similarity to the 16S rRNA sequence of the AJ297722
Kytococcus schroeteri sequence (strain Muenster 2000).
On day 1, empirical antibiotic treatment was started and,
on day 4, the child was afebrile. On day 6, the shunt was
removed and an external ventricular drain was placed. The
postoperative period was uneventful and a new VPS was
inserted after three weeks. Vancomycin and rifampin treat-
ment was discontinued on day 27. A basic immunologicalscreening was performed (IgG, A, M, G2, G3, total comple-
ment, C3 and C4) and was normal. The boy did not present
any dysmorphic features and his karyotype was 46,XY normal.
Later on, the child underwent surgical correction of his
complex cardiopathy (aortic coarctation and ventricular
septum defect) and returned to his family in Algeria.
Discussion
In 1995, the genus Micrococcus spp. was taxonomically dis-
sected into five genera, which have been reclassified into the
new hierarchic classification system of Actinobacteria clas-
sis.2,3 The genus Kytococcus was established with the type
species K. sedentarius. It was the only recognized species of
this Kytococcus genus until 2002, when a second species was
described: K. schroeteri.4
K. schroeteri has biochemical and chemotaxonomic differ-
ences from other members of the former Micrococcus genus.
Moreover, Kytococcus can be distinguished from other Micro-
coccus by their frequent resistance to penicillin and oxacillin;
this might be relevant to clinical practice. Kytococcus spp.,
considered micrococcus-like organisms, are associated with
device-related infections in a similar way to coagulase-nega-
tive Staphylococci5 and, when found in clinical specimens,
they are usually regarded as skin or mucosal contaminants.
However, these bacteria are increasingly recognized as infec-
tious agents of prosthetic material (indwelling lines, perito-
neal dialysis devices, VPSs)5 and severe infections have been
reported in immunocompromised hosts.6—8
So far, seven human infections due to Kytococcus have
been reported in the literature; one fatal hemorrhagic pneu-
monia due to K. sedentarius,6 and five endocarditis and one
pneumonia due to K. schroeteri7—12 have been described in
adult patients. This is the first pediatric case of K. schroeteri
infection to be described. The five endocarditis cases were
treated by a combination of vancomycin and gentamycin, in
association with rifampin in four cases.7—9,11 These five cases
were cured after 3—9 weeks of antibiotherapy, combined
with cardiac surgery and removal of the infected material in
four cases.7—10 A patient with pneumonia died of septic shock
before the blood culture result was known.12 All described
isolates were resistant to penicillin, cephalosporins and ery-
thromycin, and susceptible to vancomycin, imipenem, gen-
tamycin, rifampin and tetracycline. Five K. schroeteri
infections involved prosthetic heart devices.7—11 One
occurred within three months of cardiac surgery, which
suggests per-operative contamination. The four other infec-
tions occurred several years after surgery (3, 5, 10 years, and
26 months after valve replacement), which is more likely,
according to the authors, to have been caused by hemato-
genous spread, although per-operative contamination can
not be definitely excluded. Per-operative VPS contamination
manifesting itself as infection has been known to occur
several years after insertion, especially with organisms of
low virulence such as commensal skin bacteria.13 The VPS
infection reported here was diagnosed after six months, but
might have been present soon after shunt placement, as the
child presented with fever since the device was inserted. Two
of the previously described infections by this organism
occurred in an immunocompromised host (systemic steroid
treatment for asthma; diabetes).11,12 Our patient presented
with severe malnutrition and cyanotic cardiopathy, which
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The child’s immune status, the low virulence of the infecting
agent and the repeated antimicrobial courses could have
favored a slowly evolving infection of his prosthetic device.
Optimal treatment for K. schroeteri infection has not
been defined yet. A combination of vancomycin, rifampin,
in association with gentamicin in endocarditis cases, and
removal of the foreign material led to bacteriologic eradica-
tion and clinical cure for patients with endocarditis and our
VPS infection case. The accurate identification of K. schroe-
teri, concordant with the antibiotic susceptibility testing,
allowed us to choose the most appropriate antibiotic treat-
ment, according to the scarce literature data available.
Molecular identification using 16S rRNA gene sequencing is
a useful and essential tool when identification using pheno-
typic tests, including automated identification, is not defi-
nitive. Even if, in many cases, treatment can be based on the
antibiotic susceptibility profile results and a good clinical
response, the accurate identification of the pathogen might
have implications for patient management. Little is known
about K. schroeteri and increased knowledge of infections by
this organism might be helpful in determining the most
appropriate infection management course.
Conflict of interest: No conflict of interest to declare.
Acknowledgements
We thank Dr Pierre Smeesters for critical proofreading of this
manuscript. We are grateful to V. Avesani for performing the
16S rRNA gene sequencing.
References
1. Wauters G, Avesani V, Laffineur K, Charlier J, Janssens M, Van
Bosterhaut B, Delme´e M. Brevibacterium lutescens sp. nov., from
human and environmental samples. Int J Syst Evol Microbiol
2003;53:1321—5.2. Stackebrandt E, Koch C, Gvozdiak O, Shumman P. Taxonomic
dissection of the genus Micrococcus: Kocuria gen. nov., Nester-
enkonia gen. nov., Kytococcus gen. nov., Dermacoccus gen. nov.
and Micrococcus Cohn, 1872 gen. emend. Int J Syst Bacteriol
1995;45:682—92.
3. Stackebrandt E, Rainey FA, Ward-Rainey NL. Proposal for a new
hierarchic classification system, Actinobacteria classis nov. Int J
Syst Bacteriol 1997;47:479—91.
4. Becker K, Shumann P, Wu¨llenweber J, Schulte M, Weil H-P,
Stackebrandt E, et al. Kytococcus schroeteri sp. Nov., a novel
Gram-positive actinobacterium isolated from a human clinical
source. Int J Syst Evol Microbiol 2002;52:1609—14.
5. Magee JT, Burnett IA, Hindmarch JM, Spencer RC. Micrococcus
and Stomatococcus spp. From human infections. J Hosp Infect
1990;16:67—73.
6. Levenga H, Donnelly P, Blijlevens N, Verweij P, Shirango H, de
PauwB. Fatal hemorrhagic pneumonia caused by infection due to
Kytococcus sedentarius–a pathogen or passenger? Ann Hematol
2004;83:447—9.
7. Becker K, Wu¨llenweber J, Odenthal HJ, Moeller M, Shumann P,
Peters G, von Eiff C. Prosthetic valve endocarditis due to Kyto-
coccus schroeteri. Emerg Infect Dis 2003;9:1493—5.
8. Lebrun C, Bouet J, Gautier P, Avril J-L, Gaillot O. Kytococcus
schroeteri endocarditis. Emerg Infect Dis 2005:179—80.
9. Mnif B, Boujelbene I, Mahjoubi F, Gdoura R, Trabelsi I, Moalla S,
et al. Endocarditis due to Kytococcus schroeteri: case report and
review of the literature. J Clin Microbiol 2006;44:1187—9.
10. Renvoise A, Roux V, Thunv F, Riberi A, Casalta JP. Kytococcus
schroeteri, a rare agent of endocarditis. Int J Infect Dis 2008;12:
223.
11. Aepinus C, Adolph E, von Eiff C, Podbielski A, Petzch M. Kyto-
coccus schroeteri: a probably underdiagnosed pathogen in
involved prosthetic valve endocarditis. Wien Klin Wochenschr
2008;120:46—9.
12. Mohammedi I, Berchiche C, Becker K, Belkhouja K, Robert D, von
Eiff C, Etienne J. Fatal Kytococcus schroeteri bacteremic pneu-
monia. J Infect 2005;51:e11—3.
13. Vanaclocha V, Saiz-Sapena N, Leiva J. Shunt malfunction in
relation to shunt infection. Acta Neurochirurgia 1996;138:
829—34.
